T1	Outcomes 1431 1436	death
T2	Outcomes 1471 1606	survival, cardiovascular events, performance status, quality of life (QOL), symptoms, number of nonstatin medications, and cost savings
T3	Outcomes 2093 2102	Total QOL
T4	Outcomes 2232 2253	cardiovascular events
T5	Outcomes 2321 2330	Mean cost
T6	Outcomes 2530 2630	improved QOL, use of fewer nonstatin medications, and a corresponding reduction in medication costs.